TrialFind
Saved trials
Back to results
Recruiting
Phase 2
The Efficacy and Safety of Anlotinib Combined With Fulvestrant in Patients With Advanced Breast Cancer
NCT05075512
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China
Contact
Xiaojia Wang
+86 13906500190
wxiaojia0803@163.com
View on ClinicalTrials.gov
Official details
The Efficacy and Safety of Anlotinib Combined With Fulvestrant in Patients With Advanced Breast Cancer — TrialFind